Sigilon - Shielded Living Therapeutics Cell
Our Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials, potentially enabling our products to produce a wide range of therapeutic molecules that may be missing or deficient in the body, including proteins, enzymes or other therapeutic molecules.
-
Most popular related searches
Products Details
Our pipeline primarily spans a range of lysosomal and endocrine diseases, with the current focus on MPS-1 and diabetes. Our product candidates are designed to be off-the-shelf, durable, controllable and redosable, without requiring modification of the patient’s genes or complete suppression of the patient’s immune system.
Customer reviews
No reviews were found for Sigilon - Shielded Living Therapeutics Cell. Be the first to review!